UK markets closed

Akebia Therapeutics, Inc. (AKBA)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.2100-0.1200 (-9.02%)
At close: 04:00PM EDT
1.2500 +0.04 (+3.31%)
After hours: 07:44PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts3333
Avg. Estimate-0.06-0.08-0.29-0.32
Low estimate-0.08-0.11-0.37-0.58
High estimate-0.03-0.06-0.220.08
Year ago EPS-0.06-0.08-0.28-0.29
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts3333
Avg. Estimate49.51M43.58M180.68M159.52M
Low estimate45.79M41.9M164.6M125.9M
High estimate54M45.95M191.06M184M
Year ago sales56.38M42.05M194.62M180.68M
Sales growth (year/est)-12.20%3.60%-7.20%-11.70%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.02-0.08-0.04-0.08
Actual EPS-0.06-0.080-0.09
Difference-0.0400.04-0.01
Surprise %-200.00%0.00%100.00%-12.50%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.06-0.08-0.29-0.32
7 days ago-0.06-0.08-0.29-0.32
30 days ago-0.06-0.08-0.29-0.29
60 days ago-0.06-0.08-0.28-0.08
90 days ago-0.06-0.08-0.28-0.08
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesAKBAIndustrySector(s)S&P 500
Current qtr.N/AN/AN/AN/A
Next qtr.N/AN/AN/AN/A
Current year-3.60%N/AN/AN/A
Next year-10.30%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A